Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
303M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
109M
-
Shares change
-
+15.7M
-
Total reported value, excl. options
-
$588M
-
Value change
-
+$84.1M
-
Put/Call ratio
-
3.7
-
Number of buys
-
59
-
Number of sells
-
-37
-
Price
-
$5.41
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q3 2018
132 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q3 2018.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 109M shares
of 303M outstanding shares and own 35.96% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (13.5M shares), MAVERICK CAPITAL LTD (12.2M shares), BlackRock Inc. (9.97M shares), ORACLE INVESTMENT MANAGEMENT INC (9.39M shares), ARK Investment Management LLC (7.79M shares), Vanguard Group Inc (6.31M shares), Point72 Asset Management, L.P. (5.18M shares), Capital World Investors (4.68M shares), Capital International Investors (4.16M shares), and ArrowMark Colorado Holdings LLC (3.76M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.